The Journal of Immunology, Vol 153, Issue 4 1487-1494, Copyright © 1994 by American Association of Immunologists

ARTICLES

Invariant chain prevents the HLA-DR-restricted presentation of a cytosolic peptide

EO Long, T LaVaute, V Pinet and D Jaraquemada
Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20852.

Three properties of the HLA-DR-associated invariant chain (Ii) may contribute to the distinction between the class I and class II Ag presentation pathways. First, Ii prevents peptide binding to alpha beta 1 Ii complexes. Second, Ii promotes assembly of class II alpha beta heterodimers and their transport out of the endoplasmic reticulum. Third, Ii provides a targeting signal for the transport of class II molecules to endocytic compartments. However, it is not known whether Ii can prevent class II-restricted T cell recognition of endogenous peptides transported into the endoplasmic reticulum. In addition, recent evidence has indicated that, in the absence of Ii, newly synthesized class II molecules cannot form stable complexes with peptides. In this study, transfected human fibroblast cells expressing HLA-DR1 alone or with an excess of Ii were tested for their ability to present a DR1-restricted epitope of the influenza virus matrix protein produced as a short cytosolic peptide by use of an episomal expression vector. Presentation to a DR1-restricted T cell clone was very efficient in cells expressing class II molecules without Ii, but not in cells expressing class II and Ii. The inhibition by Ii was specific for the endogenous cytosolic peptide, because the same epitope processed from exogenous influenza virus particles was presented only by cells expressing class II with Ii. Ii did not inhibit the HLA-A2-restricted presentation of another cytosolic peptide. Thus, T cells can detect a cytosolic peptide loaded onto class II alpha beta heterodimers, and Ii prevents such endogenous peptide presentation.

This article has been cited by other articles:

				N. J. Poloso, L. K. Denzin, and P. A. Roche CDw78 Defines MHC Class II-Peptide Complexes That Require Ii Chain-Dependent Lysosomal Trafficking, Not Localization to a Specific Tetraspanin Membrane Microdomain J. Immunol., October 15, 2006; 177(8): 5451 - 5458. [Abstract] [Full Text] [PDF]

				E. J. Beswick, I. V. Pinchuk, K. Minch, G. Suarez, J. C. Sierra, Y. Yamaoka, and V. E. Reyes The Helicobacter pylori Urease B Subunit Binds to CD74 on Gastric Epithelial Cells and Induces NF-{kappa}B Activation and Interleukin-8 Production Infect. Immun., February 1, 2006; 74(2): 1148 - 1155. [Abstract] [Full Text] [PDF]

				J. A. Thompson, S. K. Dissanayake, B. R. Ksander, K. L. Knutson, M. L. Disis, and S. Ostrand-Rosenberg Tumor Cells Transduced with the MHC Class II Transactivator and CD80 Activate Tumor-Specific CD4+ T Cells Whether or Not They Are Silenced for Invariant Chain Cancer Res., January 15, 2006; 66(2): 1147 - 1154. [Abstract] [Full Text] [PDF]

				E. J. Beswick, D. A. Bland, G. Suarez, C. A. Barrera, X. Fan, and V. E. Reyes Helicobacter pylori Binds to CD74 on Gastric Epithelial Cells and Stimulates Interleukin-8 Production Infect. Immun., May 1, 2005; 73(5): 2736 - 2743. [Abstract] [Full Text] [PDF]

				Y. Zhao, D. Boczkowski, S. K. Nair, and E. Gilboa Inhibition of invariant chain expression in dendritic cells presenting endogenous antigens stimulates CD4+ T-cell responses and tumor immunity Blood, December 1, 2003; 102(12): 4137 - 4142. [Abstract] [Full Text] [PDF]

				T. Linnemann, G. Jung, and P. Walden Detection and Quantification of CD4+ T Cells with Specificity for a New Major Histocompatibility Complex Class II-Restricted Influenza A Virus Matrix Protein Epitope in Peripheral Blood of Influenza Patients J. Virol., September 15, 2000; 74(18): 8740 - 8743. [Abstract] [Full Text]

				S.-H. Liu, M. S. Marks, and F. M. Brodsky A Dominant-negative Clathrin Mutant Differentially Affects Trafficking of Molecules with Distinct Sorting Motifs in the Class II Major Histocompatibility Complex (MHC) Pathway J. Cell Biol., March 9, 1998; 140(5): 1023 - 1037. [Abstract] [Full Text] [PDF]

				N Barois, F Forquet, and J Davoust Actin microfilaments control the MHC class II antigen presentation pathway in B cells J. Cell Sci., January 7, 1998; 111(13): 1791 - 1800. [Abstract] [PDF]

				M. Gueguen and E. O. Long Presentation of a cytosolic antigen by major histocompatibility complex class II molecules requires a long-lived form of the antigen PNAS, December 10, 1996; 93(25): 14692 - 14697. [Abstract] [Full Text] [PDF]